Proportional Frequency and Clinical Characteristics of Gastric, Esophageal, and Gastroesophageal Junction Cancers in a Private Medical Group in Brazil
An improved understanding of GEJC characteristics in Brazil is essential for facilitating early diagnosis, identifying optimal treatment strategies, and informing public health policies. The extremely low rates of biomarker testing in this study revealed a significant gap in the implementation of modern oncology guidelines.
Institutions
- Astellas Pharma (Japan) (JP)
- Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR)
- ID Genomics (United States) (US)
- Ministério da Saúde (BR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
Publication Details
- Journal
- World Journal of Oncology
- Published
- 2025-12-19
- DOI
- https://doi.org/10.14740/wjon2551
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00